PL3363428T3 - Perfuzyjna postać dawkowania - Google Patents
Perfuzyjna postać dawkowaniaInfo
- Publication number
- PL3363428T3 PL3363428T3 PL18162403.2T PL18162403T PL3363428T3 PL 3363428 T3 PL3363428 T3 PL 3363428T3 PL 18162403 T PL18162403 T PL 18162403T PL 3363428 T3 PL3363428 T3 PL 3363428T3
- Authority
- PL
- Poland
- Prior art keywords
- dosage form
- perfusion dosage
- perfusion
- dosage
- Prior art date
Links
- 239000002552 dosage form Substances 0.000 title 1
- 230000010412 perfusion Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/10—Bag-type containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/16—Holders for containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/1407—Infusion of two or more substances
- A61M5/1408—Infusion of two or more substances in parallel, e.g. manifolds, sequencing valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B55/00—Preserving, protecting or purifying packages or package contents in association with packaging
- B65B55/02—Sterilising, e.g. of complete packages
- B65B55/04—Sterilising wrappers or receptacles prior to, or during, packaging
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D81/00—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
- B65D81/24—Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants
- B65D81/26—Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants with provision for draining away, or absorbing, or removing by ventilation, fluids, e.g. exuded by contents; Applications of corrosion inhibitors or desiccators
- B65D81/266—Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants with provision for draining away, or absorbing, or removing by ventilation, fluids, e.g. exuded by contents; Applications of corrosion inhibitors or desiccators for absorbing gases, e.g. oxygen absorbers or desiccants
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/13—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered from dispensers
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16Z—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS, NOT OTHERWISE PROVIDED FOR
- G16Z99/00—Subject matter not provided for in other main groups of this subclass
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Medical Informatics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Primary Health Care (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Mechanical Engineering (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Food Science & Technology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2804MU2014 | 2014-09-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3363428T3 true PL3363428T3 (pl) | 2024-06-10 |
Family
ID=54106163
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL18162403.2T PL3363428T3 (pl) | 2014-09-03 | 2015-09-03 | Perfuzyjna postać dawkowania |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US10098813B2 (pl) |
| EP (3) | EP4368175A3 (pl) |
| JP (4) | JP2016093480A (pl) |
| KR (1) | KR102584402B1 (pl) |
| DK (1) | DK3363428T3 (pl) |
| ES (1) | ES2985740T3 (pl) |
| FI (1) | FI3363428T3 (pl) |
| PL (1) | PL3363428T3 (pl) |
| TW (2) | TWI769126B (pl) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10098813B2 (en) * | 2014-09-03 | 2018-10-16 | Sun Pharmaceutical Industries Limited | Perfusion dosage form |
| JP6612763B2 (ja) * | 2014-10-02 | 2019-11-27 | テルモ株式会社 | タンパク質溶液製剤を収容するための医療用容器 |
| FI4011377T3 (fi) * | 2015-02-13 | 2025-01-07 | Sun Pharmaceutical Ind Ltd | Suonensisäinen infuusioannosmuoto sisältäen pemetreksediä |
| PL3413862T3 (pl) | 2016-02-09 | 2024-03-18 | Sun Pharmaceutical Industries Ltd. | Układ perfuzyjny |
| US10369077B2 (en) * | 2017-05-31 | 2019-08-06 | Adienne Pharma & Biotech Sa | Multi chamber flexible bag and methods of using the same |
| US10507165B2 (en) * | 2017-05-31 | 2019-12-17 | Adienne Pharma & Biotech Sa | Multi chamber flexible bag and methods of using same |
| US20190105262A1 (en) * | 2017-10-10 | 2019-04-11 | Sun Pharmaceutical Industries Ltd. | Intravenous infusion dosage form for pemetrexed |
| KR102632686B1 (ko) * | 2018-09-24 | 2024-02-02 | 오 파마슈티컬 컴퍼니 리미티드 | 주입 시스템 |
| CN111498207B (zh) | 2019-01-30 | 2023-05-02 | 百特国际有限公司 | 医用流体容器制备系统和方法 |
| CN113543769A (zh) | 2019-02-22 | 2021-10-22 | 太阳医药工业有限公司 | 用于静脉内使用的咪达唑仑的输注袋 |
| EP4023202A1 (en) * | 2020-12-29 | 2022-07-06 | B. Braun Melsungen AG | Medicinal product comprising a flexible plastic bag and an aqueous, ready-to-use solution of midazolam |
Family Cites Families (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4447230A (en) * | 1981-08-05 | 1984-05-08 | Quest Medical, Inc. | Intravenous administration set assembly |
| JPS62221352A (ja) * | 1986-03-22 | 1987-09-29 | 株式会社新素材総合研究所 | 酸素による薬液の変質を防止する薬液入りプラスチック容器の製造方法 |
| DE4336336A1 (de) | 1992-11-23 | 1994-05-26 | Lang Volker | Kasetteninfusionssystem |
| US5786344A (en) | 1994-07-05 | 1998-07-28 | Arch Development Corporation | Camptothecin drug combinations and methods with reduced side effects |
| US5896989A (en) * | 1998-02-20 | 1999-04-27 | Bracco Research Usa | Flexible medical container packaging |
| US6771697B1 (en) | 1998-06-23 | 2004-08-03 | Pctel, Inc. | Spread spectrum handshake for digital subscriber line telecommunications systems |
| US7235583B1 (en) | 1999-03-09 | 2007-06-26 | Luitpold Pharmaceuticals, Inc., | Fatty acid-anticancer conjugates and uses thereof |
| AU4564200A (en) | 1999-04-29 | 2000-11-17 | Aventis Pharma S.A. | Method for treating cancer using camptothecin derivatives and 5-fluorouracil |
| US7243689B2 (en) | 2000-02-11 | 2007-07-17 | Medical Instill Technologies, Inc. | Device with needle penetrable and laser resealable portion and related method |
| CA2408710C (en) | 2000-05-15 | 2010-01-26 | Celgene Corp. | Compositions and methods for the treatment of colorectal cancer |
| US7352770B1 (en) | 2000-08-04 | 2008-04-01 | Intellon Corporation | Media access control protocol with priority and contention-free intervals |
| JP2002073810A (ja) * | 2000-08-31 | 2002-03-12 | Terumo Corp | 輸液剤組成解析プログラム及びこれを用いた輸液剤処方サポートシステム |
| US20050137971A1 (en) | 2000-10-02 | 2005-06-23 | Ibm Corporation | Personally customizable credit card accounts |
| US20030039306A1 (en) | 2001-04-06 | 2003-02-27 | Redfern Arthur John | Low peak-to-average ratio quiescent mode architecture and signal design method for DMT modems |
| US20030031240A1 (en) | 2001-07-31 | 2003-02-13 | Redfern Arthur J. | Downstream only suspend-type Q-Mode |
| US6936413B1 (en) * | 2001-12-05 | 2005-08-30 | Baxter International Inc. | Methods and systems for preparing blood products |
| US6476068B1 (en) * | 2001-12-06 | 2002-11-05 | Pharmacia Italia, S.P.A. | Platinum derivative pharmaceutical formulations |
| US7122210B2 (en) * | 2002-01-11 | 2006-10-17 | Baxter International Inc. | Bicarbonate-based solutions for dialysis therapies |
| EP2546152A3 (en) | 2002-09-03 | 2014-03-26 | Medical Instill Technologies, Inc. | Sealed containers and methods of making and filling same |
| JP4787455B2 (ja) | 2002-12-12 | 2011-10-05 | テルモ株式会社 | ビタミンb1類含有水性製剤充填済み容器体を収容した包装体 |
| ES2528669T3 (es) * | 2003-04-08 | 2015-02-11 | Progenics Pharmaceuticals, Inc. | Formulaciones farmacéuticas que contienen metilnaltrexona |
| MY141763A (en) | 2003-09-18 | 2010-06-30 | Novartis Ag | Pharmaceutical products comprising bisphosphonates |
| US20080242691A1 (en) | 2004-02-13 | 2008-10-02 | Kabushiki Kaisha Yakult Honsha | Aqueous Solution Preparation Containing Camptothecins |
| CN101128230B (zh) * | 2005-02-11 | 2010-09-29 | 麻省理工学院 | 表面注射装置 |
| JP2006248978A (ja) * | 2005-03-10 | 2006-09-21 | Mebiopharm Co Ltd | 新規なリポソーム製剤 |
| JP2010503696A (ja) | 2006-09-13 | 2010-02-04 | ヌベロ, インコーポレイテッド | 癌を処置するための方法 |
| US20110177161A1 (en) | 2007-05-24 | 2011-07-21 | Dr. Reddy's Laboratories Limited | Pharmaceutical compositions of [5(s)-(2'-hydroxyethoxy)-20(s)-camptothecin |
| EP2259776A4 (en) | 2008-02-29 | 2011-03-16 | Eagle Pharmaceuticals Inc | USEFUL TOPOTECAN SOLUTIONS |
| WO2009130564A1 (en) * | 2008-04-22 | 2009-10-29 | Fidia Farmaceutici S.P.A. | Therapeutic use of new pharmaceutical preparations containing antitumoral drugs bound to hyaluronic acid in the treatment of neoplasias |
| RU2496499C2 (ru) | 2008-09-26 | 2013-10-27 | Эститю Де Кансероложи Де Л'Вест | Оптимизация индивидуальных доз 5-фторурацила при режиме folfiri |
| WO2010088973A1 (en) * | 2009-02-06 | 2010-08-12 | Shl Group Ab | Medicament delivery device with electronic dose sensor |
| EP2954913A1 (en) * | 2009-06-24 | 2015-12-16 | Carticept Medical, Inc. | Injection system for delivering multiple fluids within the anatomy |
| KR20120111721A (ko) | 2009-07-01 | 2012-10-10 | 프레제니우스 메디칼 케어 홀딩스 인코퍼레이티드 | 약물 전달 장치와 이에 관련된 시스템 및 방법 |
| SI2508170T1 (sl) * | 2009-12-03 | 2015-12-31 | Jiangsu Hengrui Medicine Co., Ltd. | Liposom z irinotekanom ali njegovim hidrokloridom in njun postopek priprave |
| JP2011250726A (ja) | 2010-06-01 | 2011-12-15 | Toyo Kohan Co Ltd | イリノテカンの副作用の発生危険度を判定する方法及びそのためのキット |
| AR085215A1 (es) | 2011-02-15 | 2013-09-18 | Sanofi Aventis Deutschland | Interfaz de dispensacion para uso con un dispositivo dispensador de farmacos que libera dos o mas agentes farmaceuticos |
| WO2012177798A2 (en) | 2011-06-20 | 2012-12-27 | Renaudia Medical, Llc | Distributed medication delivery system and method having autonomous delivery devices |
| AU2012339701B8 (en) * | 2011-11-15 | 2017-11-16 | Allergan, Inc. | Autoclavable suspensions of cyclosporin A Form 2 |
| WO2013171763A1 (en) * | 2012-04-27 | 2013-11-21 | Sun Pharmaceutical Industries Ltd | Ready to be infused gemcitabine solution |
| RU2015100517A (ru) | 2012-06-13 | 2016-08-10 | ДР. ПИ ИНСТИТЬЮТ ЭлЭлСи | Устройство, имеющее протыкаемую перегородку, заполняющую иглу и протыкаемую крышку, и связанный с ним способ |
| US9125805B2 (en) | 2012-06-27 | 2015-09-08 | Xeris Pharmaceuticals, Inc. | Stable formulations for parenteral injection of small molecule drugs |
| CN102824345B (zh) * | 2012-09-20 | 2014-03-26 | 江苏奥赛康药业股份有限公司 | 一种盐酸伊立替康组合物及其制备方法 |
| CN102885765B (zh) * | 2012-10-25 | 2013-11-06 | 哈药集团生物工程有限公司 | 一种盐酸伊立替康注射液及其制备方法 |
| CN103989624B (zh) * | 2013-02-20 | 2018-04-27 | 中国科学院上海药物研究所 | 一种盐酸伊立替康组合物及其制备方法 |
| EP3021811A1 (en) * | 2013-07-15 | 2016-05-25 | Alchemia Oncology Pty Limited | Method of pre-preparing medications for therapeutic uses |
| US10098813B2 (en) * | 2014-09-03 | 2018-10-16 | Sun Pharmaceutical Industries Limited | Perfusion dosage form |
| PL3413862T3 (pl) | 2016-02-09 | 2024-03-18 | Sun Pharmaceutical Industries Ltd. | Układ perfuzyjny |
-
2015
- 2015-09-02 US US14/843,296 patent/US10098813B2/en active Active
- 2015-09-03 PL PL18162403.2T patent/PL3363428T3/pl unknown
- 2015-09-03 TW TW104129237A patent/TWI769126B/zh active
- 2015-09-03 EP EP24153550.9A patent/EP4368175A3/en active Pending
- 2015-09-03 KR KR1020150125175A patent/KR102584402B1/ko active Active
- 2015-09-03 EP EP18162403.2A patent/EP3363428B1/en active Active
- 2015-09-03 JP JP2015174012A patent/JP2016093480A/ja active Pending
- 2015-09-03 EP EP15183635.0A patent/EP2992869A1/en not_active Withdrawn
- 2015-09-03 ES ES18162403T patent/ES2985740T3/es active Active
- 2015-09-03 FI FIEP18162403.2T patent/FI3363428T3/fi active
- 2015-09-03 TW TW111120140A patent/TWI860522B/zh active
- 2015-09-03 DK DK18162403.2T patent/DK3363428T3/da active
-
2018
- 2018-10-12 US US16/158,937 patent/US20190046398A1/en not_active Abandoned
-
2020
- 2020-10-21 JP JP2020176766A patent/JP7029510B2/ja active Active
-
2022
- 2022-01-19 JP JP2022006307A patent/JP7466579B2/ja active Active
- 2022-09-20 US US17/933,593 patent/US11793719B2/en active Active
-
2024
- 2024-04-02 JP JP2024059568A patent/JP2024088701A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4368175A2 (en) | 2024-05-15 |
| DK3363428T3 (da) | 2024-05-21 |
| KR102584402B1 (ko) | 2023-10-04 |
| EP2992869A1 (en) | 2016-03-09 |
| JP2024088701A (ja) | 2024-07-02 |
| US11793719B2 (en) | 2023-10-24 |
| FI3363428T3 (fi) | 2024-05-10 |
| JP2021038223A (ja) | 2021-03-11 |
| JP2016093480A (ja) | 2016-05-26 |
| KR20160028401A (ko) | 2016-03-11 |
| EP4368175A3 (en) | 2024-07-17 |
| ES2985740T3 (es) | 2024-11-07 |
| US20190046398A1 (en) | 2019-02-14 |
| US10098813B2 (en) | 2018-10-16 |
| US20160058663A1 (en) | 2016-03-03 |
| TWI769126B (zh) | 2022-07-01 |
| EP3363428B1 (en) | 2024-02-14 |
| EP3363428A1 (en) | 2018-08-22 |
| US20230087099A1 (en) | 2023-03-23 |
| JP2022062078A (ja) | 2022-04-19 |
| JP7029510B2 (ja) | 2022-03-03 |
| TWI860522B (zh) | 2024-11-01 |
| TW201625194A (zh) | 2016-07-16 |
| JP7466579B2 (ja) | 2024-04-12 |
| TW202245728A (zh) | 2022-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL270954A (en) | Pharmaceutical compounds | |
| GB201419579D0 (en) | Pharmaceutical compound | |
| GB201414730D0 (en) | Pharmaceutical compound | |
| GB201404922D0 (en) | Pharmaceutical compounds | |
| PL3363428T3 (pl) | Perfuzyjna postać dawkowania | |
| GB201416513D0 (en) | Pharmaceutical compounds | |
| IL247084B (en) | dose fgh–18 | |
| GB201417707D0 (en) | Pharmaceutical compounds | |
| GB201418710D0 (en) | Dosage regimen | |
| TWM488998U (en) | Syringe | |
| SG11201704819WA (en) | Syringe | |
| GB201406115D0 (en) | New pharmaceutical use | |
| IL249374A0 (en) | Pharmaceutical administration forms | |
| GB201409662D0 (en) | New pharmaceutical use | |
| GB201508022D0 (en) | Pharmaceutical compounds | |
| GB201418708D0 (en) | Dosage regimen | |
| GB201416968D0 (en) | Pharmaceutical compounds | |
| GB201416969D0 (en) | Pharmaceutical compounds | |
| GB201416625D0 (en) | Pharmaceutical compounds | |
| GB201416627D0 (en) | Pharmaceutical compounds | |
| GB201416622D0 (en) | Pharmaceutical compounds | |
| GB201411148D0 (en) | New pharmaceutical uses | |
| GB201400171D0 (en) | Dosage regimen | |
| GB201419570D0 (en) | Pharmaceutical compound | |
| GB201404896D0 (en) | Pharmaceutical compounds |